Cellares

Cellares makes cell therapies for drug developers using automated manufacturing systems. It calls itself an Integrated Development and Manufacturing Organization (IDMO): it runs its Cell Shuttle manufacturing platform and Cell Q quality-control workcell in its own Smart Factories and offers development, clinical and commercial production as a service. It has sites in South San Francisco and Bridgewater, New Jersey, with facilities planned in the Netherlands and Japan.

Health & biotechAutomated cell therapy manufacturing (contract development and manufacturing)South San Francisco, United States
FoundersSince 2019
  • Fabian GerlinghausCEO
  • Omar KurdiPresident
  • Alex Pesch
Total raised
$682M
Last round · Jun 2026
Series D (extension)
Founded
2019

Funding rounds

DateRound · leadRaised
Jun 15, 2026Series D (extension)$50M
Jun 9, 2026Series D (extension)$20M
Jan 28, 2026Series D · BlackRock, Eclipse$257M
Aug 23, 2023Series C · Koch Disruptive Technologies$255M
May 5, 2021Series B · Decheng Capital, Eclipse Ventures$82M
2019Series A · Eclipse Ventures$18M

Team

  • Fabian Gerlinghaus
    Co-Founder and CEO
  • Omar Kurdi
    Co-Founder and President
  • Alex Pesch
    Co-founder
  • Ossama Eissa
    Chief Operating Officer
  • Ali Soleymannezhad
    Chief Commercial Officer